HC Wainwright Trims Inhibrx Target to $220 After Wider Loss; Shares Fall 6.77%
HC Wainwright cut its INBX price target to $220 from $245 and kept its Buy rating, blaming higher other expenses for a wider quarterly loss. Shares closed at $77.66, down 6.77% from Friday.




